Publications
- New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity2022 | First Faculty of Medicine
- Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas2017 | First Faculty of Medicine
- Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity2012 | First Faculty of Medicine
- Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-alpha in transformed astrocytic cells2011 | First Faculty of Medicine
- Modulation of substance P signaling by dipeptidyl peptidase-IV enzymatic activity in human glioma cell lines2008 | First Faculty of Medicine
- Impact of experimentally modified cell growth on the Dipeptidyl peptidase-IV activity and/or structure homologues (DASH) in cultured glioma cell linesPublication without faculty affiliation
- Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells2024 | First Faculty of Medicine
- Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours2023 | First Faculty of Medicine
- Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting2023 | First Faculty of Medicine
- Chorobné znaky a příznaky : diferenciální diagnostika2022 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
Loading network view...
